Biogen Inc. (BIIB) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$173.90

-$0.5

(-0.29%)

Day's range

$172.95

$176.95

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$276.38

58.93% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
10/31/2024	Oppenheimer	Jay Olson	$255.00	$181.18	40.74%
10/31/2024	Morgan Stanley	Terence Flynn	$204.00	$181.18	12.6%
10/30/2024	Raymond James	Christopher Raymond	$315.00	$181.18	73.86%
10/30/2024	Goldman Sachs	Salveen Richter	$290.00	$181.18	60.06%
10/17/2024	BMO Capital	Evan Seigerman	$230.00	$188.17	22.23%
10/03/2024	UBS	Ashwani Verma	$202.00	$188.74	7.03%
09/23/2024	Wedbush	Laura Chico	$205.00	$199.36	2.83%
07/29/2024	Robert W. Baird	Brian Skorney	$294.00	$212.70	38.22%
07/26/2024	Goldman Sachs	Salveen Richter	$342.00	$211.17	61.95%
07/26/2024	Piper Sandler	Christopher Raymond	$307.00	$211.17	45.38%
07/26/2024	RBC Capital	Brian Abrahams	$282.00	$214.16	31.68%
07/12/2024	Piper Sandler	Christopher Raymond	$313.00	$236.80	32.18%
07/11/2024	Morgan Stanley	Terence Flynn	$311.00	$232.75	33.62%
06/12/2024	Scotiabank	George Farmer	$275.00	$230.28	19.42%
05/23/2024	BMO Capital	Evan David Seigerman	$260.00	$220.00	18.18%
05/22/2024	Stifel Nicolaus	Paul Matteis	$275.00	$225.21	22.11%
05/22/2024	Raymond James	Christopher Raymond	$335.00	$225.21	48.75%
05/22/2024	Morgan Stanley	Matthew Harrison	$331.00	$224.48	47.45%
04/25/2024	Wedbush	Laura Chico	$215.00	$204.65	5.06%
04/25/2024	H.C. Wainwright	Andrew Fein	$300.00	$201.99	48.52%
04/25/2024	RBC Capital	Brian Abrahams	$317.00	$201.99	56.94%
04/19/2024	Oppenheimer	Jay Olson	$270.00	$190.52	41.72%
04/03/2024	Barclays	Carter Gould	$215.00	$206.38	4.18%
08/07/2023	Wedbush	Laura Chico	$269.00	$271.23	-0.82%
05/01/2023	Guggenheim	Yatin Suneja	$350.00	$311.11	12.5%
09/28/2022	Needham	Ami Fadia	$250.00	$271.17	-7.81%
09/28/2022	Morgan Stanley	Matthew Harrison	$285.00	$271.14	5.11%
09/28/2022	Atlantic Equities	Steve Chesney	$200.00	$271.17	-26.24%
09/28/2022	Mizuho Securities	Salim Syed	$270.00	$197.79	36.51%
09/28/2022	BMO Capital	Evan David Seigerman	$360.00	$197.79	82.01%
09/27/2022	Robert W. Baird	Brian Skorney	$340.00	$197.79	71.9%
09/27/2022	Needham	Ami Fadia	$250.00	$197.79	26.4%
04/18/2022	Wells Fargo	Mohit Bansal	$265.00	$212.55	24.68%
04/06/2022	Piper Sandler	Christopher Raymond	$200.00	$211.64	-5.5%
04/06/2022	Robert W. Baird	Brian Skorney	$224.00	$211.64	5.84%
04/06/2022	Jefferies	Michael Yee	$300.00	$211.64	41.75%
04/04/2022	RBC Capital	Brian Abrahams	$244.00	$207.61	17.53%
03/27/2022	Bank of America Securities	Geoff Meacham	$225.00	$211.68	6.29%
03/14/2022	BMO Capital	Evan Seigerman	$238.00	$197.36	20.59%
02/27/2022	Canaccord Genuity	Sumant Kulkarni	$285.00	$211.01	35.06%
02/21/2022	Guggenheim	Yatin Suneja	$200.00	$209.81	-4.68%
02/15/2022	Truist Financial	Robyn Karnauskas	$320.00	$214.55	49.15%
02/06/2022	Mizuho Securities	Salim Syed	$207.00	$221.30	-6.46%
02/03/2022	Wells Fargo	Mohit Bansal	$235.00	$221.53	6.08%
02/03/2022	Barclays	Carter Gould	$235.00	$221.53	6.08%
02/03/2022	Wolfe Research	Tim Anderson	$217.00	$221.53	-2.04%
02/03/2022	Morgan Stanley	Matthew Harrison	$330.00	$221.53	48.96%
02/03/2022	Cowen & Co.	Phil Nadeau	$285.00	$221.53	28.65%
02/02/2022	J.P. Morgan	Cory Kasimov	$236.00	$220.17	7.19%
01/11/2022	Cantor Fitzgerald	Alethia Young	$209.00	$225.34	-7.25%
01/02/2022	Bernstein	Aaron Gal	$400.00	$244.14	63.84%
12/05/2021	Goldman Sachs	Salveen Richter	$271.00	$224.11	20.92%
10/19/2021	UBS	Colin Bristow	$405.00	$266.57	51.93%
06/07/2021	Atlantic Equities	Steve Chesney	$415.00	$395.37	4.96%

Biogen Inc. Frequently Asked Questions

What analysts cover Biogen Inc.?

Biogen Inc. has been rated by research analysts at Oppenheimer, Morgan Stanley, Raymond James, Goldman Sachs, BMO Capital, UBS in the past 90 days.

Get The App

Biogen Inc. (BIIB) Analyst Forecast

Consensus Rating

Consensus Price Target

Recent Analyst Forecasts and Stock Ratings

Biogen Inc. Frequently Asked Questions

What analysts cover Biogen Inc.?

Select an alert type

Setup alert

Premium Content

Log In

Email Verification

Welcome to Stocks.News!

Create Your Account

Email Verification